Advertisement

Search Results

Advertisement



Your search for James O. Armitage, MD matches 54 pages

Showing 51 - 54


lymphoma

Indolent Lymphoma: A More Complex Malignancy Than Once Thought

With a growing number of options for follicular lymphoma, clinicians may wonder whether there is one best regimen. James O. Armitage, MD, FACP, FRCP, Professor of Medicine at the University of Nebraska, Omaha—and Editor-in-Chief of The ASCO Post—tackled this question and offered recommendations at...

lymphoma
solid tumors

ASCO Clinical Practice Guideline Update: Recommendations for the Use of White Blood Cell Growth Factors

ASCO has issued a clinical practice guideline update on use of hematopoietic colony-stimulating factors, as reported in the Journal of Clinical Oncology by Thomas J. Smith, MD, FACP, FASCO, FAAHMP, and colleagues.1 This update to the ASCO 2006 guideline was based on a systematic review of...

Journal of Oncology Practice Expands Research Coverage and Debuts a New Look

Launched by ASCO in 2005 to provide oncologists with original research on the delivery of high-quality cancer care, the Journal of Oncology Practice (JOP) enters its 11th year with a new look and feel. Beginning in January 2016, JOP will be copublished by ASCO and Harborside Press, the publisher of ...

supportive care

ASCO Clinical Practice Guideline Update: Recommendations for Using White Blood Cell Growth Factors

ASCO has issued a clinical practice guideline update on the use of hematopoietic colony-stimulating factors, as reported in the Journal of Clinical Oncology by Smith et al. This update to the ASCO 2006 guideline was based on a systematic review of randomized clinical trials, meta-analyses, and ...

Advertisement

Advertisement



Advertisement